These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 14728994)

  • 1. Glucocerebrosidase mutations in subjects with parkinsonism.
    Lwin A; Orvisky E; Goker-Alpan O; LaMarca ME; Sidransky E
    Mol Genet Metab; 2004 Jan; 81(1):70-3. PubMed ID: 14728994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinsonism among Gaucher disease carriers.
    Goker-Alpan O; Schiffmann R; LaMarca ME; Nussbaum RL; McInerney-Leo A; Sidransky E
    J Med Genet; 2004 Dec; 41(12):937-40. PubMed ID: 15591280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations.
    Goker-Alpan O; Lopez G; Vithayathil J; Davis J; Hallett M; Sidransky E
    Arch Neurol; 2008 Oct; 65(10):1353-7. PubMed ID: 18852351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between ß-glucocerebrosidase mutations and parkinsonism.
    Swan M; Saunders-Pullman R
    Curr Neurol Neurosci Rep; 2013 Aug; 13(8):368. PubMed ID: 23812893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between mutations in the lysosomal protein glucocerebrosidase and parkinsonism.
    DePaolo J; Goker-Alpan O; Samaddar T; Lopez G; Sidransky E
    Mov Disord; 2009 Aug; 24(11):1571-8. PubMed ID: 19425057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the link between glucocerebrosidase mutations and parkinsonism.
    Westbroek W; Gustafson AM; Sidransky E
    Trends Mol Med; 2011 Sep; 17(9):485-93. PubMed ID: 21723784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational modelling approaches as a potential platform to understand the molecular genetics association between Parkinson's and Gaucher diseases.
    Thirumal Kumar D; Eldous HG; Mahgoub ZA; George Priya Doss C; Zayed H
    Metab Brain Dis; 2018 Dec; 33(6):1835-1847. PubMed ID: 29978341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Complicated Relationship between Gaucher Disease and Parkinsonism: Insights from a Rare Disease.
    Aflaki E; Westbroek W; Sidransky E
    Neuron; 2017 Feb; 93(4):737-746. PubMed ID: 28231462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional brain imaging in glucocerebrosidase mutation carriers with and without parkinsonism.
    Kono S; Ouchi Y; Terada T; Ida H; Suzuki M; Miyajima H
    Mov Disord; 2010 Sep; 25(12):1823-9. PubMed ID: 20669267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocerebrosidase mutations are not found in association with LRRK2 G2019S in subjects with parkinsonism.
    Eblan MJ; Scholz S; Stubblefield B; Gutti U; Goker-Alpan O; Hruska KS; Singleton AB; Sidransky E
    Neurosci Lett; 2006 Aug; 404(1-2):163-5. PubMed ID: 16781064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neurobiology of glucocerebrosidase-associated parkinsonism: a positron emission tomography study of dopamine synthesis and regional cerebral blood flow.
    Goker-Alpan O; Masdeu JC; Kohn PD; Ianni A; Lopez G; Groden C; Chapman MC; Cropp B; Eisenberg DP; Maniwang ED; Davis J; Wiggs E; Sidransky E; Berman KF
    Brain; 2012 Aug; 135(Pt 8):2440-8. PubMed ID: 22843412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
    Alcalay RN; Levy OA; Waters CC; Fahn S; Ford B; Kuo SH; Mazzoni P; Pauciulo MW; Nichols WC; Gan-Or Z; Rouleau GA; Chung WK; Wolf P; Oliva P; Keutzer J; Marder K; Zhang X
    Brain; 2015 Sep; 138(Pt 9):2648-58. PubMed ID: 26117366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the glucocerebrosidase gene are common in patients with Parkinson's disease from Eastern Canada.
    Han F; Grimes DA; Li F; Wang T; Yu Z; Song N; Wu S; Racacho L; Bulman DE
    Int J Neurosci; 2016; 126(5):415-21. PubMed ID: 26000814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gaucher disease and parkinsonism, a molecular link theory.
    Goldin E
    Mol Genet Metab; 2010 Dec; 101(4):307-10. PubMed ID: 20801700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gaucher-Associated Parkinsonism.
    Li Y; Li P; Liang H; Zhao Z; Hashimoto M; Wei J
    Cell Mol Neurobiol; 2015 Aug; 35(6):755-61. PubMed ID: 25820783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocerebrosidase mutations are also found in subjects with early-onset parkinsonism from Venezuela.
    Eblan MJ; Nguyen J; Ziegler SG; Lwin A; Hanson M; Gallardo M; Weiser R; De Lucca M; Singleton A; Sidransky E
    Mov Disord; 2006 Feb; 21(2):282-3. PubMed ID: 16261622
    [No Abstract]   [Full Text] [Related]  

  • 17. Functional analysis of 13 GBA mutant alleles identified in Gaucher disease patients: Pathogenic changes and "modifier" polymorphisms.
    Montfort M; Chabás A; Vilageliu L; Grinberg D
    Hum Mutat; 2004 Jun; 23(6):567-75. PubMed ID: 15146461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocerebrosidase mutations in primary parkinsonism.
    Asselta R; Rimoldi V; Siri C; Cilia R; Guella I; Tesei S; Soldà G; Pezzoli G; Duga S; Goldwurm S
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1215-20. PubMed ID: 25249066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gaucher disease: complexity in a "simple" disorder.
    Sidransky E
    Mol Genet Metab; 2004; 83(1-2):6-15. PubMed ID: 15464415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?
    Tayebi N; Walker J; Stubblefield B; Orvisky E; LaMarca ME; Wong K; Rosenbaum H; Schiffmann R; Bembi B; Sidransky E
    Mol Genet Metab; 2003 Jun; 79(2):104-9. PubMed ID: 12809640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.